Agreements: the Lifeblood of an Emerging Company

Speakers: Adam Schoen & Sam Williams, Partners, Brown Rudnick

Zoom Webinar
Tuesday, December 8, 1:00 to 2:00 PM PST

Agreements are the lifeblood of any emerging company. License agreements typically allow founders to bring their technology out of the academic setting and into their companies. Master service agreements are a very common avenue by which emerging companies work with vendors to accomplish research objectives. Collaboration agreements typically define relationships between a company and an industry partner or larger strategic. Understanding these agreements and avoiding pitfalls are critical. This talk with explain the different aspects of such agreements and how they are viewed by venture investors and other strategic partners.

Weathering the Storm: Surviving (and Thriving) During a Pandemic

Harith Rajagopala

Speaker: Harith Rajagopalan, M.D., Ph.D., Co-Founder & CEO, Fractyl


Zoom Webinar
Wednesday, November 11, 1:00 to 2:00 PM PST

2020 has been an unbelievably difficult year for everyone and has thrown special obstacles in the way of startup founders. Doing labwork, pitching investors, conducting trials: it can seem like nothing is easy or even possible. Yet you can make progress. Who could confirm this better than Harith Rajagopalan, CEO of Fractyl? Fractyl, whose technology treats patients with type 2 diabetes, received an Investigational Device Exemption from the FDA this June; and in August closed a $55 million round to fund global clinical trials. How did Harith do it?

How to Match Your Value Proposition with Strategic Needs

Speaker: Holly Sheffield, President, CooperSurgical

Zoom Webinar
Thursday, October 22, Noon to 1:00 PM PST

Startup founders put years of blood, sweat, and tears into their companies, often with the end goal of strategic acquisition. All their work may be in vain, though, if they have not thought and planned in advance about the strategic needs of the acquirer. Understanding how strategics do their due diligence, the key areas/metrics they look for to make the acquisition and the areas they will be interested in when your technology is ripe for acquisition.

What should YOU be thinking about?

Join us to learn from Holly Sheffield, president of CooperSurgical, a leading medtech company that has acquired more than 13 companies in the past 5 years. Prior to joining CooperSurgical, Ms. Sheffield had a 20+ year career as an investment banker, advising companies on strategic acquisitions.